← Back to Clinical Trials
Recruiting NCT06248073

NCT06248073 Effectiveness of Online Program and Task-related Training for Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06248073
Status Recruiting
Phase —
Sponsor Chang Gung University
Condition Parkinson Disease
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-03-01
Primary Completion 2027-07-31

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
on-line self-management trainingonsite task-related training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-03-01 with a primary completion date of 2027-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare the effectiveness of online self-management program and on-site task-related training for people with early stage Parkinson's disease. people with early stage of Parkinson's disease (age range: 45-70 years) will be randomly assigned into the following three groups: control group, online self-management program group and on-site task-related training group.The control group will receive no treatment during the experimental period. For the other two groups, participants will receive the intervention twice a week, one hour per session and 12 sessions in total. The main questions it aims to answer are: 1. the potential impact of motor and non-motor symptoms on activity participation and quality of life for people with early stage of Parkinson's disease (PD). 2. compare and examine the the effectiveness of online self-management program and on-site task-related training for people with early stage Parkinson's disease on activity participation and quality of life.

Eligibility Criteria

Inclusion criteria: 1. Willingness to sign the informed consent form. 2. Age between 45 and 70 years, with mild idiopathic Parkinson's disease and Hoehn and Yahr stage 1-2. 3. No cognitive impairment. 4. No severe depression that could affect the motivation to participate in the study. 5. No history of shoulder dislocation or fracture that could affect body proprioception. 6. No diseases that could affect the ability to reach for objects, such as stroke. 7. No diseases that could affect peripheral sensation, such as diabetes. 8. No severe tremors; patients whose hands, when relaxed and placed on the apparatus, still exhibit significant tremor interfering with the experiment will not be included. 9. Able to follow instructions and complete the assessment process. 10. Have not received physical or occupational therapy in the past year. Exclusion criteria: 1. Other central nervous system diseases, such as stroke. 2. Have major surgery on the head or upper limbs. 3. Inability to perform the reaching task while sitting.

Contact & Investigator

Central Contact

Kuan-yi Li, PhD

✉ kyli@mail.cgu.edu.tw

📞 +886 32118800

Principal Investigator

Kuan-yi Li, PhD

PRINCIPAL INVESTIGATOR

Chang Gung University

Frequently Asked Questions

Who can join the NCT06248073 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 70 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06248073 currently recruiting?

Yes, NCT06248073 is actively recruiting participants. Contact the research team at kyli@mail.cgu.edu.tw for enrollment information.

Where is the NCT06248073 trial being conducted?

This trial is being conducted at Linkou District, Taiwan.

Who is sponsoring the NCT06248073 clinical trial?

NCT06248073 is sponsored by Chang Gung University. The principal investigator is Kuan-yi Li, PhD at Chang Gung University. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology